These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 14622931)
21. Role of NK1 tachykinin receptors in thermonociception: effect of (+/-)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice. Lecci A; Giuliani S; Patacchini R; Viti G; Maggi CA Neurosci Lett; 1991 Aug; 129(2):299-302. PubMed ID: 1720881 [TBL] [Abstract][Full Text] [Related]
22. A potent nonpeptide antagonist of the substance P (NK1) receptor. Snider RM; Constantine JW; Lowe JA; Longo KP; Lebel WS; Woody HA; Drozda SE; Desai MC; Vinick FJ; Spencer RW Science; 1991 Jan; 251(4992):435-7. PubMed ID: 1703323 [TBL] [Abstract][Full Text] [Related]
23. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Lai JP; Ho WZ; Zhan GX; Yi Y; Collman RG; Douglas SD Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3970-5. PubMed ID: 11274418 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory action of (+/-)CP-96,345 on the cardiovascular responses to intrathecal substance P and neuropeptide K in the conscious freely moving rat. Pham TM; Couture R Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):34-41. PubMed ID: 7680439 [TBL] [Abstract][Full Text] [Related]
25. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062 [TBL] [Abstract][Full Text] [Related]
26. Efficient tritiation of the translocator protein (18 kDa) selective ligand DPA-714. Damont A; Garcia-Argote S; Buisson DA; Rousseau B; Dollé F J Labelled Comp Radiopharm; 2015 Jan; 58(1):1-6. PubMed ID: 25616229 [TBL] [Abstract][Full Text] [Related]
27. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity. Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096 [TBL] [Abstract][Full Text] [Related]
28. Tritium labelling and characterization of the antimalarial drug (+/-)-chloroquine by several methods. Egan JA; Laseter AG; Filer CN Appl Radiat Isot; 2002 Sep; 57(3):343-5. PubMed ID: 12201140 [TBL] [Abstract][Full Text] [Related]
29. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs. Chahl LA; Johnston PA Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540 [No Abstract] [Full Text] [Related]
30. Analysis of a nonpeptide antagonist for substance P on myenteric neurons of guinea-pig small intestine. Tamura K; Mutabagani K; Wood JD Eur J Pharmacol; 1993 Mar; 232(2-3):235-9. PubMed ID: 7682179 [TBL] [Abstract][Full Text] [Related]
31. Ventilatory responses to hypoxia in rats pretreated with nonpeptide NK1 receptor antagonist CP-96,345. De Sanctis GT; Green FH; Jiang X; King M; Remmers JE J Appl Physiol (1985); 1994 Apr; 76(4):1528-32. PubMed ID: 7519186 [TBL] [Abstract][Full Text] [Related]
32. Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord. Garces YI; Rabito SF; Minshall RD; Sagen J Life Sci; 1993; 52(4):353-60. PubMed ID: 7678436 [TBL] [Abstract][Full Text] [Related]
33. Tritiation of imipramine and pseudo irreversible analogues 3-cyanoimipramine and 2-nitroimipramine at high specific activity. Ahern DG; Johnson E; Laseter AG; Filer CN Appl Radiat Isot; 2006 Jul; 64(7):798-801. PubMed ID: 16556503 [TBL] [Abstract][Full Text] [Related]
34. Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro. Houben H; Denef C Peptides; 1993; 14(1):109-15. PubMed ID: 7680128 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14. Šamonina-Kosicka J; Kańska M J Labelled Comp Radiopharm; 2013 May; 56(6):317-20. PubMed ID: 24285411 [TBL] [Abstract][Full Text] [Related]
36. Effects of FK224, a novel cyclopeptide NK1 and NK2 antagonist, and CP-96,345, a nonpeptide NK1 antagonist, on development and maintenance of thermal hyperesthesia evoked by carrageenan injection in the rat paw. Yamamoto T; Shimoyama N; Mizuguchi T Anesthesiology; 1993 Nov; 79(5):1042-50. PubMed ID: 7694526 [TBL] [Abstract][Full Text] [Related]
37. A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons. Wang X; Douglas SD; Commons KG; Pleasure DE; Lai J; Ho C; Bannerman P; Williams M; Ho W J Neurosci Res; 2004 Feb; 75(4):544-53. PubMed ID: 14743438 [TBL] [Abstract][Full Text] [Related]
38. Tritiation of alpha-bungarotoxin with N-succinimidyl [2,3-3H]propionate. A useful reagent for labelling proteins. Dolly JO; Nockles EA; Lo MM; Barnard EA Biochem J; 1981 Mar; 193(3):919-23. PubMed ID: 7305967 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptor. Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Moorman AR; Di Virgilio F; Cattabriga E; Pancaldi C; Gessi S; Borea PA Bioorg Med Chem Lett; 2004 Nov; 14(22):5709-12. PubMed ID: 15482953 [TBL] [Abstract][Full Text] [Related]
40. A selective and potent antagonist of substance P receptors on pancreatic acinar cells. Sjödin L; Gylfe E Biochem Int; 1992 Jun; 27(1):145-53. PubMed ID: 1378274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]